59: Hide & Seq: An ID Fellow Primer on Molecular Diagnostics

1

Introduction

00:00 • 2min

2

The New Frontier in Diagnostics and Antibiotic Resistance

01:43 • 2min

3

DNA and RNA in Diagnostics and Infectious Disease

03:22 • 2min

4

Is There a Difference Between PCR and PCR?

05:21 • 3min

5

PCR Cycle Threshold Values With COVID

07:51 • 2min

6

The PCR Assay for COVID-19?

09:28 • 1min

7

Clinical Infectious Diseases

10:57 • 3min

8

PCR Based Detection of Infectious Disease

13:29 • 3min

9

Broad Range Bacterial PCR Testing

16:27 • 1min

10

Sanger Sequencing of the 16s Ribosomal RNA Gene in Bacteria

17:56 • 3min

11

Is 18s or Sometimes I Hear About 28s?

20:36 • 2min

12

Is There a Mycobacterium?

22:15 • 2min

13

Sequencing Mycobacteria

24:06 • 2min

14

Identifying a Specific Brucella Species

25:37 • 2min

15

The Challenges of Next Generation Sequencing

27:17 • 2min

16

Those Taxonomists Are Not the Most Popular People in Infectious Disease

28:55 • 2min

17

The 16s, 28s and PCR Platforms for ID Clinicians

30:27 • 2min

18

Sanger Sequencing in Clinical Infectious Diseases

32:11 • 1min

19

Infective Endocorditis and Next Generation PCR Detection

33:23 • 3min

20

How Does Next Generation Sequencing Affect Clinical Infectious Diseases?

36:12 • 2min

21

Sequencing for Detection of Pathogens

37:52 • 4min

22

Clinical Infectious Diseases - Disease by Disease

41:28 • 3min

23

The Limitations of Unbiased Sequencing in CSF

44:26 • 3min

24

Is Sequencing a First Line Test?

47:21 • 2min

25

Is There a Better Way to Use Microlab and Clinical ID Tests?

49:30 • 1min

26

Detection of Bacteria

50:54 • 2min

27

The Future of Oncology and Immunomodulation

52:38 • 2min